from Reuters: Business News https://ift.tt/2IYUU1l
Friday, July 6, 2018
Hitting cancer early: AstraZeneca's bid to outmaneuver rivals
LONDON (Reuters) - AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.
from Reuters: Business News https://ift.tt/2IYUU1l
from Reuters: Business News https://ift.tt/2IYUU1l
Related Posts:
Despite Tiger Woods, PGA Championship ticket prices hit 4-year lows- Singapore PM says call to curb online violence 'effective'
- Graduating job applicants ranked location, starting salary as top priorities, Monster survey shows
- Top 10 best and worst US states for economy
- Bryce Harper's slump: After signing huge contracts, these stars struggled
0 comments:
Post a Comment